Dr. Vokes Discusses PARP Inhibitors in Lung Cancer

October 12, 2017
Everett E. Vokes, MD

Everett E. Vokes, MD, John E. Ultmann Professor of Medicine and Radiation Oncology, physician-in-chief, University of Chicago Medicine, and biological sciences chair, department of medicine, discusses PARP inhibitors for the treatment of lung cancer.